Loading clinical trials...
Loading clinical trials...
An Open Label Clinical Trial of Metformin in Those With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Conditions
Interventions
Metformin Hydrochloride
Locations
1
United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Start Date
February 14, 2022
Primary Completion Date
December 30, 2027
Completion Date
July 15, 2028
Last Updated
April 15, 2026
NCT04469439
NCT06154447
NCT05422222
NCT06984679
NCT02417740
NCT05359991
Lead Sponsor
University of Kansas Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions